Objective: To examine the association between compliance with hospital accreditation and 30-day mortality. Design: A nationwide population-based, follow-up study with data from national, public registries. Setting: Public, non-psychiatric Danish hospitals. Participants: In-patients diagnosed with one of the 80 primary diagnoses. Intervention: Accreditation by the first version of The Danish Healthcare Quality Programme for hospitals from 2010 to 2012. Compliance were assessed by surveyors on an on-site survey and awarded the hospital as a whole; fully (n = 11) or partially accredited (n = 20). A follow-up activity was requested for partially accredited hospitals; submitting additional documentation (n = 11) or by having a return-visit (n = 9). Main Outcome Measure(s): All-cause mortality within 30-days after admission. Multivariable logistic regression was used to compute odds ratios (ORs) for 30-day mortality adjusted for six confounding factors and for cluster effect at hospital level. Results: A total of 276 980 in-patients were identified. Thirty-day mortality risk for in-patients at fully (n = 76 518) and partially accredited hospitals (n = 200 462) was 4.14% (95% confidence interval (CI):4.00-4.28) and 4.28% (95% CI: 4.20-4.37), respectively. In-patients at fully accredited hospitals had a lower risk of dying within 30-days after admission than in-patients at partially accredited hospitals (adjusted OR of 0.83; 95% CI: 0.72-0.96). A lower risk of 30-day mortality was observed among in-patients at partially accredited hospitals required to submit additional documentation compared with in-patients at partially accredited hospitals requiring a return-visit (adjusted OR 0.83; 95% CI: 0.67-1.02). Conclusion: Admissions at fully accredited hospitals were associated with a lower 30-day mortality risk than admissions at partially accredited hospitals.
Introduction
Despite considerable use of accreditation to ensure quality in healthcare, studies on its effectiveness remain sparse [1] [2] [3] [4] . Previous systematic reviews have reached diverging conclusions [1] [2] [3] . A positive association between accreditation and professional development, and some processes of care, has been demonstrated [3, 5] . However, little is known about the impact of accreditation on clinical outcomes and more insight is needed to justify the substantial effort dedicated to achieve compliance with accreditation programmes [4] .
Few studies have examined the association between accreditation of healthcare organizations and patient mortality, mainly by studying differences between accredited and non-accredited hospitals or before and after accreditation was introduced [6] [7] [8] [9] [10] . Reduced in-hospital mortality was found in favour of accreditation in three studies [6, 8, 9] , while two studies were unable to demonstrate such differences [7, 10] . The studies were limited by examining only the possible role of accreditation in relation to specific conditions (i.e. acute myocardial infarction or acute ischaemic stroke) and in counting in-hospital death, only. A US study analysed the association between the accredited hospitals' overall compliance with the accreditation programme and mortality for patients with acute myocardial infarction also and found a higher mortality risk for partially and not accredited hospitals compared with fully accredited hospitals [9] . However, the overall evidence-base understanding regarding the relation between accreditation and patient outcomes remain weak and in combination with the worldwide use of accreditation to evaluate healthcare organizations more insight is clearly warranted.
Therefore, we examined the association between compliance with national accreditation programme and 30-day mortality after admittance to Danish hospitals. The hypothesis was that the risk of dying within 30 days after admission was lower for in-patients admitted at hospitals fully compliant with the accreditation programme than for in-patients admitted at hospitals partially compliant.
Methods
A nationwide population-based follow-up study was performed covering in-patients admitted to public, non-psychiatric hospitals in Denmark during 15 November 2009 to 10 December 2012. Denmark's 5.6 million inhabitants have unfettered access to hospitals because of publicly funding through taxes. All inhabitants are assigned a unique central personal registry number at birth or at immigration enabling accurate and unambiguous individual-level record linkage across all public registries [11] .
Accreditation of the Danish healthcare system
The first version of Danish Healthcare Quality Programme (DDKM) for hospitals was launched in 2009 and met the requirements of ISQua's international principles for developing healthcare standards [12] . The vision of DDKM is multi-dimensional, ranging from highlighting the quality of health care to preventing errors that cause death and lower quality of life [13] .
Accreditation by the DDKM is mandatory for all public Danish hospitals, thus all hospitals were accredited between 2010 and 2012 [14] . The DDKM comprised of 104 standards divided into 453 measurable elements (e.g. an indicator or a criterion). The standards incorporated the Plan-Do-Check-Act circle and were grouped into organizational, general patient pathway and disease-specific standards (an English version is available at http://www.ikas.dk/IKAS/English. aspx).
A team of surveyors judged hospital's compliance to the DDKM during an on-site survey. Hospital performance was assessed on a three-dimensional scale by means of interviewing staff, reviewing guidelines and, to a lesser extent, observing procedures and conducting tracers. Based on these findings, the hospital as a whole was awarded a level of accreditation; 'Accredited', 'Accredited with comments' or 'Conditionally accredited' (first proceeding). Hospitals awarded 'accredited with comments' or 'conditionally accredited' were offered a follow-up activity in order to support improvements. If the majority of the deficiencies were related to the 'Do'-part of the quality circle, a return-visit by a reduced survey team would take place, whereas hospitals with deficiencies mainly related to the 'Plan, Study or Act'-parts were given the opportunity to submit additional documentation. Based on completion of the follow-up activity, a final level of accreditation was awarded (final proceeding). All survey reports are fully accessible at a public website, including information on the level of accreditation, and compliance with standards and measurable elements [15] .
A total of 34 public, non-psychiatric hospitals were accredited by the DDKM between 2010 and 2012. Three hospitals were excluded from this study due to the nature of patient population treated (hospitals treating only: obstetric and pregnant patients, elective patients, and in-patients undergoing intensive care or anaesthesia). Compliance with accreditation was defined in accordance with the first proceeding, where 11 hospitals were accredited and 20 were accredited with comments, in this paper referred to as fully accredited and partially accredited hospitals (no hospitals were conditionally accredited). Fully accredited hospitals had at most one standard partially or not met, while partially accredited hospitals had between 2 and 22 standards partially or not met. Follow-up activity in the form of a return-visit took place at 10 of the partially accredited hospitals whereas the remaining 11 hospitals submitted additional documentation. Hospitals characteristics including previous accreditation (yes/no), university affiliation (yes/no) and time of survey (before/after July 2011) are presented in Table 2 . As these characteristics may be linked with mortality, their roles as possible confounding factors/effect modifiers of the association between compliance with hospital accreditation and mortality were examined in stratified analyses [16, 17] .
Owing to the DDKM's multi-dimensional vision, some standards were intended to have a greater impact on mortality than others. An expert panel with profound knowledge of the DDKM and/or the Danish healthcare system was appointed to identify standards with a priori expected impact on 30-day mortality. Independently, the experts picked the standards considered to have impact on 30-day mortality and subsequently prioritized these in terms of importance. A standard was selected for further analysis if all three criteria were fulfilled; (i) at least three experts had selected the standard as important, (ii) the standard was ranked among the 25 most important, and (iii) at least three hospitals were partially or non-compliant. Four standards fulfilled the inclusion criteria. We defined hospitals compliant with all four standards as compliant hospitals (n = 22; corresponding to 11 fully and 11 partially accredited hospitals in the first proceeding) and hospitals partially or not compliant with one or more of the standards as non-compliant (n = 9; all partially accredited hospitals in the first proceeding).
As a supplementary analysis, we reassessed the original level of accreditation by applying the updated rating principles of 2012 to account for any possible misclassification of the accreditation level [15] . The new rating principles were developed to ensure a transparent allocation to the accreditation level. Three specialists reassessed all partially and non-compliant standards using a pre-specified protocol Table continued Accreditation and mortality • Quality Assessment and any differences were resolved after discussion and consensus. The reassessment resulted in a lower level of accreditation for five hospitals of which two hospitals were lowered to 'conditionally accredited' defined as 'non-accredited hospitals'. For the selection of standards with a priori expected impact on 30-day mortality, the reassessment resulted in 12 standards fulfilled the inclusion criterion listed in the paragraph above. The numbers of standards increased, as a higher proportion of hospitals was classified partially compliant due to tougher requirements for fulfilling an indicator. Again, hospitals were defined as compliant if all 12 standards were fulfilled (n = 7; five fully and two partially accredited hospitals) and hospitals as noncompliant if one or more standards were partially fulfilled (n = 24; 6 fully and 18 partially accredited hospitals).
Study population
The Danish National Registry of Patients (DNRP) was used to identify all in-patients admitted from 15 November 2009 to 10 December 2012 [18] . The registry encompasses information on all admissions and discharges from all Danish non-psychiatric hospitals. Based on all admissions in 2008 we identified the primary diagnoses, listed in Table 1 , (n = 80) which accounted for 80% of all deaths occurring within 30 days after admission at Danish hospitals. These diagnoses have been used since 2008 to compute hospital-standardized mortality ratio [19] . To reduce the heterogeneity of the included patients, the present study was restricted to in-patients with one of these 80 diagnoses. In-patients were included if admission took place in a 12-month inclusion period for each hospital; computed from ±6 month from the hospitals first day of on-site survey. We considered this period appropriate as an enhanced effort to meet the accreditation requirements started ∼6 months before the on-site survey and additional work to become fully compliant to the DDKM ended within 6 months after the on-site survey. If the in-patients had more than one admission in the hospitals inclusion period, we included only the first admission. In-patients with an invalid civil registration number, e.g. foreign nationals treated in Danish hospitals, were excluded. A flowchart of the identification of the study population is presented in Fig. 1 .
Mortality
The outcome was death from any cause within 30 days after admission. Information on all-cause mortality was obtained from The Danish Civil Registration System, regardless of whether the patient was admitted or discharged at the time of death [11] . Since 1968, this registry has recorded all changes in vital status and migration for the entire Danish population on a daily basis and is regarded as highly accurate.
Covariates
As potential confounding factors, information was obtained from DNRP on age (<50 years, 50-64, 65-80 and >80 years), gender, primary diagnosis (in 11 categories corresponding to ICD-10s chapters), type of admission (acute and elective), marital status (married, unmarried, divorced, and widow (obtained and defined by the Danish Civil Registration System)) and comorbidity. The Charlson comorbidity index was used to assess comorbidity [20] . The index assigns between one and six points to a range of diseases, depending on their relation to mortality in the subsequent year during the era when the index was developed. The predictive value of the diagnoses included in the Charlson index has previously been shown to be high in DNRP [21] . All diagnoses registered in DNRP on admission (since 1977) or outpatient contact (since 1995), prior to the time of inclusion in this study, were included in the calculations of a comorbidity score. If the patient's primary diagnosis was one of the 19 conditions Spinal muscular atrophy and related syndromes originally included in the index, we modified the comorbidity score by not taking the condition into account when computing the score for the patient. On the basis of this method, a comorbidity score was computed for each patient and three categories were defined (no comorbidity, low, and high (≥3 comorbidities)).
Statistical analysis
In-patients were followed up from the date of admission until 30 days after admission or date of death, whichever occurred first. In the primary analysis, 30-day mortality of in-patients admitted at fully accredited hospitals were compared with 30-day mortality in-patients at partially accredited hospital. The analysis was repeated with partially accredited hospitals divided according to the type of follow-up activity. Secondary analyses examined the association between compliance to the four selected standards and 30-day mortality by comparing in-patients admitted at compliant with non-compliant hospitals. These analyses were done for both the entire study population and for subgroups of in-patients in which hospital compliance with two of the selected standards individually were presumed to be of particular importance, see Table 1 (i.e. compliance with 'Observation and follow-up on critical observations results' was based on in-patients Categories of comorbidity were based on Charlson comorbidity index scores (no comorbidity = 0, low = 1 and 2, and high = ≥3). with acute critical conditions (15 diagnoses) and 'Treatment of cardiac arrest' on in-patients with cardiovascular diseases (10 diagnoses)). All analyses were also repeated in supplementary analysis using the updated rating principles from 2012. Multivariable logistic regression was performed in all analyses to compute odds ratio (OR) and 95% confidence interval (95% CI). In all analyses we controlled for the covariates described above. Robust standard error adjustment was used to account for a possible withinhospital clustering because in-patient at the one hospital are more likely treated similarly relative to in-patients at another hospital (minimize the risk of type-1 error). Stratified analyses were conducted according to hospitals characteristics; previous accredited (yes/no), university affiliation (yes/no) and time of on-site survey (June 2010 to June 2011/July 2011 to June 2012) to examine the role of calendar time.
Differences <0.05 were considered statistical significant. All analyses were performed using STATA, version 12 (StataCorp. 2011. College Station, TX: StataCorp LP).
Results
The final study cohort consisted of 276 980 in-patients, of whom 76 518 were admitted at fully accredited hospitals (27.63%) and 200 462 at partially accredited hospitals (72.37%). Baseline patient characteristics are presented in Table 2 .
Of the included 276 980 in-patients, 11 755 died within 30-days of admission. The 30-day mortality risk for in-patients at fully accredited hospitals was 4.14% (95% CI 4.00-4.28) and 4.28% (95% CI 4.20-4.37) for in-patients at partially accredited hospitals. Mortality risk including crude and adjusted ORs are presented in Table 3 . A lower risk of dying within 30-days of admission was found for in-patients at fully accredited hospitals than for in-patients at partially accredited hospitals (adjusted OR 0.83; 95% CI 0.72-0.96). Dividing partially accredited hospitals according to the type of follow-up activity revealed that in-patients at hospitals requested to submit documentation were less likely to die within 30 days of admission compared with in-patients at hospitals having a return-visit (adjusted OR 0.83; 95%CI 0.67-1.02). Stratifying for previous accreditation, university affiliation and time of on-site survey did not substantially change the estimates (data not shown).
For the four standards with a priori expected impact on 30-day mortality risk, we found a similar pattern with in-patients admitted at compliant hospitals having a lower 30-day mortality risk than inpatient at non-compliant hospitals (adjusted OR 0.82; 95% CI 0.70-0.97); see Table 3 . The association was particularly strong for When examining the association between compliance with the individual standards and 30-day mortality risk in subgroups of the study population, we found that in-patients with acute critical conditions admitted at hospitals compliant with the standard 'Observation and follow-up on critical observation results' (n = 10 445) had a substantially lower 30-day mortality risk than corresponding in-patients admitted to non-compliant hospitals (n = 27 019) (adjusted OR 0.49; 95% CI 0.37-0.65). Likewise patients with cardiovascular disease admitted to hospitals compliant with the standard 'Treatment of cardiac arrest' (n = 8 169) had a lower 30-day mortality risk than cardiovascular in-patients admitted to non-compliant hospitals (n = 17 629) (adjusted OR 0.61; 95% CI 0.38-0.99).
The findings from the primary analyses were corroborated by the results of the supplementary analyses where hospitals were classified according to the rating principles of 2012. Here 64 563 in-patients were admitted at fully accredited hospitals (23.31%), 188 585 at partially accredited hospitals (68.09%) and 23 832 at non-accredited hospitals (8.60%). The proportion of in-patients dying within 30 days of admission was 4.06% (95% CI 3.91-4.21) at fully accredited hospitals, 4.23% (95% CI 4.14-4.32) at partially accredited hospitals and 4.85% (95% CI 4.57-5.12) for in-patients at not accredited hospitals. Mortality risk including crude and adjusted estimates are presented in Table 4 . Using in-patients at partially accredited hospitals as reference group, the adjusted ORs for death within 30 days after admission were 0.87 (95% CI 0.74-1.02) for in-patients at fully accredited hospitals and 1.18 (95% CI 1.05-1.34) for in-patients at not-accredited hospitals, respectively.
Discussion
The present study is the first nationwide study to explore the association between compliance to accreditation standards and 30-day mortality. We found a lower 30-day mortality risk for in-patients with one of the 80 selected diagnoses admitted at fully accredited hospitals compared with in-patients at partially accredited hospitals. This finding was corroborated in all of the additionally analyses performed.
Strengths and weaknesses
The strengths of the study included the nationwide, population-based design, the availability of prospectively collected comprehensive patient data and the complete follow-up that limits the risk of selection and information bias. Furthermore, the control for important patient characteristics in the analyses such as gender, age and comorbidities Adjusted for age, gender, comorbidity, primary diagnose, type of admission, and marital status, including robust standard error at hospital level based on data from 276 977 in-patients and the robustness of the findings across a range of subgroup and alternative analyses reduces the risk that the findings could be explained by confounding. The limitations included the accuracy of the DDKM accreditation data, including the unknown inter-reliability of assessments made by surveyors and survey teams [22, 23] . However, hospitals were accredited by the same accreditation programme within 2 years and any potential misclassification would most likely be of a non-differential nature and bias the results towards the null. The standard was not relevant for two hospitals as no in-patients were treated with cardiac insufficient. The standard was not relevant for ten hospitals as no in-patients were treated with perforated gastric ulcer.
Information on disease severity was not available in the medical registries for which reason unaccounted confounding cannot be excluded. Furthermore, we cannot exclude the possibility that our results may be influenced by residual or unaccounted confounding due to the nonrandomized design, although substantial efforts were made to account for possible confounding. Thus, before generalizing our findings to other accreditation programmes and settings differences must be evaluated to identify how potential differences could modify our results.
Comparison with other studies
Our study extends the findings from the study by Chen et al. based on 3179 surveyed US hospitals [6] . The study compared 30-day mortality risk after haematopoietic stem-cell transplantation according to four levels of compliance to accreditation standards provided by the Joint Commission. A higher mortality risk was found in partially and not accredited hospitals compared with fully accredited hospitals which agreed with our findings (crude hazard ratio; partially: 1.15 and not accredited: 1.06). Similarly to the DDKM accreditation, the vast majority of the hospitals were accredited with recommendation (2668 out of 3179 hospitals) but no attempts were made by Chen et al. in order to subcategorize these hospitals.
Despite years of using accreditation, only two randomized controlled trials were identified in a Cochrane review that examined the effect of accreditation [2] . In Denmark a political decision of a mandatory accreditation programme for public hospitals hampered the possibility to perform a randomized controlled trial. On the other hand, it may be questioned whether randomized control accreditation trials will be appropriate to reach firm conclusions since there are large methodological challenges in exploring complicated and contextsensitive methods like accreditation by an experimental design [24, 25] . Furthermore, accreditation is primarily introduced either by healthcare's authorities or as a financial incentive which will reduce the possibility to find eligible participants for such a design.
Perspectives
Our findings lend to support the hypothesis that compliance with accreditation standards is associated with improved clinical outcomes, including lower patient mortality. However, the nature of this association remains to be further clarified. Although better compliance with the accreditation standards was associated with lower mortality risk in our study, this does not necessarily reflect that the accreditations standards per se were responsible for the lower mortality. In addition to accreditation, a number of other nationwide quality improvement initiatives have been launched within the last decade in Denmark. This includes a Danish version of Institute of Healthcare Improvement's 100 000 Lives Campaign (active from 2007 to 2009) and continuous indicator monitoring and auditing through Clinical Quality Databases covering major disease areas including stroke, heart failure, diabetes and hip fracture. It is likely that these initiatives may have had a direct effect on patient mortality. However, the possibly impact of these initiatives does not preclude that compliance with hospital accreditation may play a role and perhaps even a causal one in relation to a reduced patient mortality. In fact, an ability to effectively implement other quality improvement initiatives could well be a direct consequence of shaping and training an organization according to the accreditation standards. Alternatively, high compliance with the accreditation standards could just be non-causal markers of high-performing hospitals, which are characterized by delivering high-quality care that ensure good clinical outcomes, including low mortality risks. More insights into the effect of accreditation on patient outcomes and processes of care, including the cost-effectiveness of this quality improvement strategy, are clearly needed.
Conclusion
The 30-day mortality risk was lower for in-patients admitted at hospitals fully accredited by the first version of the DDKM than for inpatients admitted to partially accredited hospitals. Further efforts are warranted in order to determine whether the association is causal.
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